Editorial Board

Matthew Kennedy, PhD
Associate Editor
Merck Research Laboratories
Boston, United States
Term Expiration:
12/31/2019
Areas of Interest:
pharmacology, disease modifying therapies for Alzheimer's disease
Ki Woong Kim, MD, Prof. MD PhD
Associate Editor
Seoul National University Bundang Hospital and Seoul National University College of Medicine
Seongnamsi, South Korea
Term Expiration:
12/31/2020
Areas of Interest:
cognitive disorder, old age psychiatry
Kasper Kepp, Ph.D.
Associate Editor
Technical University of Denmark
Copenhagen, Denmark
Term Expiration:
12/31/2019
Areas of Interest:
physical chemistry and biochemistry, protein evolution, biometals, computational models
Shokei Kim-Mitsuyama, M.D. Ph.D.
Associate Editor
Kumamoto University Graduate School of Medical Sciences
Kumamoto, Japan
Term Expiration:
12/31/2019
Areas of Interest:
pathophysiology and novel therapeutics of Alzheimer’s disease, vascular cognitive impairment and stroke, clinical pharmacology, pathophysiology of metabolic syndrome and cardiovascular and renal diseases
Silke Kern, MD, PhD
Associate Editor
Institute of Neuroscience and Physiology, Department of Neurochemistry and Psychiatry at Sahlgrenska Academy at the University of Gothenburg
Gothenburg, Sweden
Term Expiration:
12/31/2019
Areas of Interest:
CSF biomarkers for preclinical AD
Jessica Kirkland Caldwell, Ph.D.
Associate Editor
Cleveland Clinic Lou Ruvo Center for Brain Health
Las Vegas, United States
Term Expiration:
12/31/2021
Areas of Interest:
dementia, sex differences, MRI, functional MRI (fMRI)
Bhumsoo Kim, PhD
Associate Editor
University of Michigan
Ann Arbor, United States
Term Expiration:
12/31/2021
Areas of Interest:
Alzheimer's disease, diabetes, insulin, insulin-like growth factor-I (IGF-I)
Wolff Kirsch, MD
Associate Editor
Loma Linda University
Loma Linda, United States
Term Expiration:
12/31/2022
Areas of Interest:
aging, amyloid angiopathy, free radicals, heme degradation

Pages